Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses how GC4419 may assist in delivering more effective radiation therapy at ASTRO Head and Neck Symposium 2016.
GC4419 appears to decrease duration of oral mucositis #hncs16
Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses how GC4419 appears to decrease duration of oral mucositis at ASTRO Head and Neck Symposium 2016.
Trial Results of Superoxide Dismotase Mimetic GC4419 to Reduce Chemoradiotherapy-induced Oral Mucositis #hncs16
Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses the trial results of Superoxide Dismotase Mimetic GC4419 to Reduce Chemoradiotherapy-induced Oral Mucositis at ASTRO Head and Neck Symposium 2016.
Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses the GC4419 mechanism of action at ASTRO Head and Neck Symposium 2016.
Free Tissue Transfer in tongue and oropharynx defects helps intelligibility of speech #hncs16
Lisa Shnayder, MD of the University of Kansas Medical Center discusses how free tissue transfer can help intelligibility of speech in tongue and oropharynx defects at ASTRO Head and Neck Symposium 2016.
New cost saving technologies for reconstructing mandible after cancer treatment #hncs16
Lisa Shnayder, MD of the University of Kansas Medical Center discusses the new cost saving technologies for reconstructing a mandible after cancer treatment at ASTRO Head and Neck Symposium 2016.
Challenges reconstructing oral cavity defects after treatment #hncs16
Lisa Shnayder, MD of the University of Kansas Medical Center discusses the challenges reguarding reconstructing oral cavity defects after treatment at ASTRO Head and Neck Symposium 2016.
No clear data HPV increases risk of oral cavity cancer #hncs16
Lisa Shnayder, MD of the University of Kansas Medical Center high;lights that there is no clear data HPV increases risk of oral cavity cancer at ASTRO Head and Neck Symposium 2016.
Most HPV-positive oropharyngeal cancer can be found through imaging and physical exams within six months after treatment
Jessica M. Frakes, MD of Moffitt Cancer Center states that HPV-positive oropharyngeal cancer can be found through imaging and physical exams within six months after treatment at ASTRO Head and Neck Symposium 2016.
Jessica M. Frakes, MD of Moffitt Cancer Center discusses why NCCN guidelines may not be best management of HPV+ patients after treatment at ASTRO Head and Neck Symposium 2016.
Uninsured and Medicaid patients more likely advanced tumors in head and neck cancer #hncs16
Thomas Churilla, MD of Fox Chase Cancer Center discusses Uninsured and Medicaid patients with head and neck cancer more likely to present with advanced tumors, experience cancer specific mortality at ASTRO Head and Neck Symposium 2016.
Ezra Cohen, MD of the University of California at San Diego discusses new agents in clinical trials that appear interesting and potentially valuable additions to the therapeutic armamentarium for SCCHN at ASTRO Head and Neck Symposium 2016.
Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses how GC4419 may assist in delivering more effective radiation therapy at ASTRO Head and Neck Symposium 2016.